Dr Abeer Shaaban

Queen Elizabeth Hospital Birmingham & University of Birmingham
Specialist Breast Pathologist

Dr Shaaban is a specialist breast pathologist at Queen Elizabeth Hospital Birmingham and Honorary Senior Lecturer at the University of Birmingham. She is Breast Pathology Clinical Advisor for West Midlands, Member of Big 18 group, Lead of NCRI CM-PATH Workstream 2 (clinical trials) and member of the International Committee of the Royal College of Pathologists.

She completed her PhD in molecular pathology at the University of Liverpool, did her pathology training at the West Midlands and Yorkshire regions before working as consultant pathologist in Leeds then Birmingham. She has led and contributed to a number of breast research studies and breast cancer trials and
published over 100 papers in the field. Dr Shaaban was member of the NCRI breast CSG and chair of the Translational Subgroup of the NCRI Breast Clinical Studies Group.

dont miss

Breast Pathology: Assessing tumour response to neoadjuvant chemotherapy and endocrine therapy– Pathological considerations

The seminar will cover issues related to the multidisciplinary approach and pathological handling of neoadjuvant chemotherapy specimens, methods of histological assessment, importance of radiological correlation and recent developments including tumour bed biopsies.

EVEN MORE SEMINARS

  • Professor Robert Thomas: Speaking at the Oncology Convention

    Professor Robert Thomas
    Bedford and Addenbrooke's Cambridge University Hospitals

    Evidence based lifestyle strategies after cancer - a research review

  • Islam Elkonaissi: Speaking at the Oncology Convention

    Islam Elkonaissi
    The Royal Marsden NHS Foundation Trust

    The Multi-Specialty Challenge of Cancer Care

  • Anita McWhirter: Speaking at the Oncology Convention

    Anita McWhirter
    The Royal Marsden NHS Foundation Trust

    Pan London SACT Verification Passport for Pharmacy

  • Tim Windle: Speaking at the Oncology Convention

    Tim Windle
    Prostate Cancer UK

    Why research isn’t enough for patient access: the technology appraisal process

  • Chris Carrigan: Speaking at the Oncology Convention

    Chris Carrigan
    Bowel Cancer Intelligence UK

    Patient Engagement in the uses of Patient Data